OQROGet OQRO Pro
Insider trade

ResMed| (RMD)Director sold ~$1.8M

Peter C Farrell, Director at ResMed|, sold ~$1.8M of ResMed| shares.

~$1.8M
Approx. value · 8,000 sh @ $225.00
53K
Holds after · shares reported
Traded
Aug 5, 2026
Filed
Aug 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of RMD — reported range $1,001 - $15,000
  2. Jun 8, 2026InsiderCEO sold ~$968K of RMD shares in the open market
  3. Jun 25, 2026FDARecall: Resmed Astral 100/150 Resmed Astral 100/50 is a ventilator system that provides continuous or intermittent ventilatory support for patients weighing more than…
  4. Jun 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  5. Jul 7, 2026InsiderCEO sold ~$1.09M of RMD shares in the open market
  6. Aug 5, 2026 · this disclosureInsiderDirector sold ~$1.8M of RMD shares in the open market

What came next

  1. Aug 6, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  2. Aug 7, 20265% stakeAustralianSuper Pty Ltd reported a passive stake (13G) of 5.7%
  3. Aug 7, 2026InsiderCEO sold ~$1.03M of RMD shares in the open market
  4. Aug 13, 2026Company filing · Form 8-K · Auditor change, Executive changeChanged its auditor, and changed a top executive or board member (and 1 more item)“On August 13, 2026, Ronald Taylor, a director of Resmed, informed the Board that he will not stand for election at Resmed’s 2026 annual meeting of stockholders (the “Annual Meeting”) and intends to retire from the Board, effective at the Annual Meeting, which is expected to be held on November 18, 2026.”
  5. Aug 27, 2026FDAFDA device clearance: EasyCare Tx 2
  6. Sep 2, 2026InsiderDirector sold ~$228K of RMD shares in the open market
  7. Sep 8, 2026InsiderCEO sold ~$1.11M of RMD shares in the open market
  8. Oct 7, 2026InsiderCEO sold ~$1.13M of RMD shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for ResMed|

For ResMed|, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 19 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RMD page.

Other recent filings by Peter C Farrell, Director

The full history of Peter C Farrell, Director is on the profile page.

How this filing works

Other disclosures at ResMed|

Everything OQRO holds on this company is on its RMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data